Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-024062
Filing Date
2025-03-14
Accepted
2025-03-14 18:20:46
Documents
1
Period of Report
2025-03-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm259281-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm259281-1_4seq1.xml 4 11480
  Complete submission text file 0001104659-25-024062.txt   13107
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560
Business Address
Ali Asif (Reporting) CIK: 0001921163 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 25741676